Anthracycline-based regimens and trastuzumab related cardiotoxicity after adjuvant therapy in early breast cancer: A single center experience

被引：0
|
作者：
Iannace, A. [1 ]
Franzese, E. [2 ]
Losanno, T. [1 ]
Manna, G. [1 ]
Longo, F. [1 ]
Filomeno, L. [2 ]
Rossini, D. [1 ]
Seminara, P. [2 ]
机构：
[1] Univ Roma La Sapienza, Policlin Umberto I, Expt Med Oncol Unit A, Rome, Italy
[2] Univ Roma La Sapienza, Policlin Umberto I, Clin Med Oncol Unit A, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2086
引用
收藏
页码：S472 / S472
页数：1
相关论文
共 50 条
  • [21] Risk of cardiotoxicity induced by adjuvant anthracycline-based chemotherapy and radiotherapy in young and old Asian women with breast cancer
    Lee, Chih-Hsin
    Zhang, Jun-Fu
    Yuan, Kevin Sheng-Po
    Wu, Alexander T. H.
    Wu, Szu-Yuan
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (07) : 629 - 639
  • [22] Late-onset cardiotoxicity in Anthracycline-based chemotherapy for breast cancer patients
    Mata Caballero, R.
    Serrano Antolin, J. M.
    Gonzalez Garcia, I. A.
    Muniz Garcia, J.
    Curcio Ruigomez, A.
    Gutierrez Landaluce, C.
    Morales Garcia, L. J.
    Del Castillo Arrojo, S.
    Guerra Martinez, J. A.
    Graupner Abad, C.
    Jimenez Hernandez, R. M.
    Cristobal Varela, C.
    Malon Gimenez, D.
    Talavera Calle, P.
    Alonso Martin, J. J.
    EUROPEAN HEART JOURNAL, 2016, 37 : 118 - 119
  • [23] Early and late onset cardiotoxicity following anthracycline-based chemotherapy in breast cancer patients: Incidence and predictors
    Serrano, Jose M.
    Mata, Rebeca
    Gonzalez, Iria
    Del Castillo, Silvia
    Muniz, Javier
    Morales, Luis J.
    Espinosa, Maria Jesus
    Moreno, Fernando
    Jimenez, Rosa
    Cristobal, Carmen
    Graupner, Catherine
    Talavera, Pedro
    Landaluce, Carlos Gutierez
    Curcio, Alejandro
    Alonso, Javier
    Guerra, Juan A.
    Alonso, Joaquin J.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 382 : 52 - 59
  • [24] Incidence of anthracycline-induced cardiotoxicity in patients with breast cancer: A single center's experience
    Nadeem, O.
    Rauwerdink, C.
    Beggs, V. L.
    Parr, D. D.
    Kono, A. T.
    Schwartz, G. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Concomitant radiotherapy, and anthracycline-based chemotherapy in adjuvant breast cancer treatment
    Ivaldi, G. B.
    Leonardi, M.
    Ferrari, A.
    Morra, A.
    Fossa, B. Jereczek
    Vavassori, A.
    Santoro, L.
    Orecchia, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S180 - S181
  • [26] Irreversible cardiotoxicity after adjuvant treatment with trastuzumab in a case of breast cancer
    Bordin, Paolo
    Volpe, Carla
    Adami, Gianna
    Moretti, Valentino
    Ermacora, Paola
    TUMORI, 2008, 94 (05) : 777 - 778
  • [27] Adjuvant antibody therapy with trastuzumab in early breast cancer
    Untch, Michael
    Scharl, Anton
    Jackisch, Christian
    Thomssen, Christoph
    Nitz, Ulrike
    von Minckwitz, Gunter
    Harbeck, Nadia
    BREAST CARE, 2006, 1 (04) : 252 - 255
  • [28] Menstrual disorders during anthracycline-based adjuvant chemotherapy in very young early breast cancer patients
    Neskovic-Konstantinovic, Z.
    Strbac, D.
    Susnjar, S.
    Vukotic, D.
    Gavrilovic, D.
    BREAST, 2007, 16 : S42 - S42
  • [29] The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer
    Nolan, Luke
    Darby, Angela
    Boleti, Katia
    Simmonds, Peter
    BREAST, 2011, 20 (02): : 151 - 154
  • [30] GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment
    Zarate, R.
    Gonzalez-Santigo, S.
    de la Haba, J.
    Bandres, E.
    Morales, R.
    Salgado, J.
    Gomez, A.
    Aranda, E.
    Garcia-Foncillas, J.
    CURRENT DRUG METABOLISM, 2007, 8 (05) : 481 - 486
12345